Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis.

Singh SP, Singh V, Kar N, Chan K.

Br J Psychiatry. 2010 Sep;197(3):174-9. doi: 10.1192/bjp.bp.109.067710. Review. Erratum in: Br J Psychiatry. 2011 Feb;198:159.

2.

Bupropion for depression in schizophrenia.

Englisch S, Inta D, Eer A, Zink M.

Clin Neuropharmacol. 2010 Sep-Oct;33(5):257-9. doi: 10.1097/WNF.0b013e3181f5a5f9.

PMID:
20852411
4.

An open trial of adjunctive sertraline in the treatment of chronic schizophrenia.

Thakore JH, Berti C, Dinan TG.

Acta Psychiatr Scand. 1996 Sep;94(3):194-7.

PMID:
8891087
5.

Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.

Zisook S, Kasckow JW, Lanouette NM, Golshan S, Fellows I, Vahia I, Mohamed S, Rao S.

J Clin Psychiatry. 2010 Jul;71(7):915-22. doi: 10.4088/JCP.09m05699gre.

PMID:
20361918
6.

Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis.

Sepehry AA, Potvin S, Elie R, Stip E.

J Clin Psychiatry. 2007 Apr;68(4):604-10.

PMID:
17474817
7.

Clinical update on amisulpride in deficit schizophrenia.

Rein W, Turjanski S.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S19-27. Review.

PMID:
9218164
8.

Management of the negative symptoms of schizophrenia: new treatment options.

Möller HJ.

CNS Drugs. 2003;17(11):793-823. Review.

PMID:
12921492
9.

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study.

Jockers-Scherübl MC, Bauer A, Godemann F, Reischies FM, Selig F, Schlattmann P.

Int Clin Psychopharmacol. 2005 Jan;20(1):27-31.

PMID:
15602113
10.

Treating negative symptoms.

Bailey P, Duval F, Macher JP.

Br J Psychiatry. 1994 May;164(5):699-700. No abstract available.

PMID:
7921730
11.

A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.

Ghaleiha A, Noorbala AA, Farnaghi F, Hajiazim M, Akhondzadeh S.

J Clin Psychopharmacol. 2010 Dec;30(6):678-82.

PMID:
21105281
12.

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.

Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG.

Arch Gen Psychiatry. 1997 Jun;54(6):549-57.

PMID:
9193196
13.

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.

Leiderman E, Zylberman I, Zukin SR, Cooper TB, Javitt DC.

Biol Psychiatry. 1996 Feb 1;39(3):213-5. No abstract available.

PMID:
8837983
14.
15.

Treatment of secondary depression in schizophrenia. A double-blind, placebo-controlled trial of amitriptyline added to perphenazine.

Prusoff BA, Williams DH, Weissman MM, Astrachan BM.

Arch Gen Psychiatry. 1979 May;36(5):569-75.

PMID:
373665
16.

Depressive symptoms and schizophrenia a psychopharmacological approach.

Mauri MC, Bravin S, Fabiano L, Vanni S, Boscati L, Invernizzi G.

Encephale. 1995 Sep-Oct;21(5):555-8.

PMID:
8529564
17.

Antidepressants for the treatment of depression in people with schizophrenia: a systematic review.

Whitehead C, Moss S, Cardno A, Lewis G.

Psychol Med. 2003 May;33(4):589-99. Review.

PMID:
12785461
18.

[Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].

Philipp M, Lesch OM, Schmauss M, Dose M, Glaser T.

Psychiatr Prax. 2003 May;30 Suppl 2:S94-6. German.

PMID:
14509050
19.

Quetiapine has a direct effect on the negative symptoms of schizophrenia.

Tandon R.

Hum Psychopharmacol. 2004 Dec;19(8):559-63.

PMID:
15486960
20.

[Clozapine and treatment of negative symptoms].

Lançon C, Farisse J, Llorca PM.

Encephale. 1997 Sep;23 Spec No 4:7-11. Review. French.

PMID:
9417403

Supplemental Content

Support Center